Swedish Pharma AB - Company Review
SummarySwedish Pharma AB - Company Review
Summary
Swedish Pharma AB (Swedish Pharma) is a biotechnology company that offers development and commercialization of novel and advanced patch technologies. The company has its expertise in fields of medicine, pharmacology, novel patch technology, drug delivery systems, development and design. It also offers bioadhesive patch technology platform for dry delivery that can be used on both wet and dry skin types. Swedish Pharma’s research investigated design, physicochemical characterization and clinical evaluation of a new drug delivery system for PDT treatment. The company develops proprietary products using properties of its patch. Swedish Pharma is headquartered in Orebro, Sweden.
This comprehensive company report of Swedish Pharma AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.